Share
Tramadol Use and Renal Disease in Garoua (Cameroon)
Gloria Ashuntantang
(Author)
·
Hilaire Dominique Ewodo Touna
(Author)
·
Marie José Essi
(Author)
·
Our Knowledge Publishing
· Paperback
Tramadol Use and Renal Disease in Garoua (Cameroon) - Ewodo Touna, Hilaire Dominique ; Ashuntantang, Gloria ; Essi, Marie José
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Tuesday, August 13 and
Tuesday, August 20.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Tramadol Use and Renal Disease in Garoua (Cameroon)"
Kidney disease is a public health problem because of: Its ever-increasing incidence The high associated mortality and the cost of its management. It affects 10% of adults worldwide in its chronic form. Hypertension, diabetes, chronic infections are the main risk factors but also nephrotoxic substances. Which represents 5% of the causes. Among these nephrotoxic substances: analgesics occupy a proportion of 20%, but also Opiates (heroin and cocaine). However, in sub-Saharan Africa, and in Cameroon in particular, tramadol, a second-tier analgesic derived from opioids, used clinically for the treatment of pain, has been increasingly found in illicit channels and abused since 2003. In addition, the increase in the number of patients with end-stage renal disease, which rose from 30 in 2000 to 497 in 2012 in Cameroon, has led to the question of whether chronic users of tramadol are at risk of developing renal disease.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.